Close

BioAsia 2019 Life sciences 4.0 : Disrupt the disruption

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

BioAsia 2019 – the 16th edition of the widely attended annual convention, is all set to bring together the global industry leaders, researchers, policy makers, innovators, and investors together on one platform discussing the new opportunities in the transition.

BioAsia 2019, as a unique meeting platform for leaders from across the industry, will offer the right opportunities to catch the right notes and develop strategies to succeed in emerging markets like India. Join us during BioAsia 2019 and contribute to building an ecosystem that rewards all the stakeholders. This year at BioAsia 2019 we have more and unparalleled opportunities to learn and network than ever before.

Theme – Disrupt the disruption

 Healthcare is being reimagined globally as a result of scientific and technological advances. Ubiquity of mobile, peer-to-peer sharing tools, and experience of engaging personalized services in other areas of their lives (for e.g. retail and transportation industries) is changing consumers into super consumers. Pricing pressures are forcing Governments / healthcare authorities to prioritize better health outcomes at reduced costs. While true innovation will continue to be relevant, the government is increasingly promoting the prescription of generics and biosimilar.

Digital health start-ups and technology entrants are already moving aggressively into the mainstream by developing innovative and low cost products, services and solutions.

It is critical for all companies to invest strategically and differentially in the capabilities that create future value for all stakeholders. Life sciences companies in India, must determine how they can seize the upside of disruption in today’s transformative age to:

    Maintain leadership in the evolving generics industry
    Start gaining share in the biosimilars and personalized medicines market

BioAsia 2019 is themed on Life Sciences 4.0 where the global industry experts will share their thoughts on global trends and ramifications for all industry stakeholders viz. companies, policy makers, healthtech companies, startups, hospitals, scientists, etc.

We invite you to participate in the BioAsia 2019 conference and DISRUPT THE DISRUPTION!

  • 50+ Countries
  • 100+ High Profile Speakers
  • 800+ Corporates
  • 1000+ Partnering Meetings

Click here for more information:   http://2019.bioasia.in/

Latest stories